Chat with us
Research Assistance
Online
  • Please enter your first name.

South Africa Sepsis Diagnostics Market Size & Outlook

The sepsis diagnostics market in South Africa is expected to reach a projected revenue of US$ 14.0 million by 2033. A compound annual growth rate of 7.1% is expected of South Africa sepsis diagnostics market from 2026 to 2033.

  • Clinical Diagnostics
    • In Vitro Diagnostics
      • Sepsis Diagnostics Market Outlook
Revenue, 2025 (US$M)
$8.1
Estimate, 2026 (US$M)
$8.6
Forecast, 2033 (US$M)
$14.0
CAGR, 2026 - 2033
7.1%
South Africa Sepsis Diagnostics Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

GVR research-powered AI

Ask Prism AI about the sepsis diagnostics market

Get cited answers from GVR research on market growth, segments, regulations and forecasts.

  • Source-linked answers
  • Market-specific context
  • Traceable figures
Explore Prism AI

South Africa sepsis diagnostics market highlights

  • The South Africa sepsis diagnostics market generated a revenue of USD 8.1 million in 2025 and is expected to reach USD 14.0 million by 2033.
  • The South Africa market is expected to grow at a CAGR of 7.1% from 2026 to 2033.
  • In terms of segment, conventional diagnostics was the largest revenue generating method in 2025.
  • Automated Diagnostics is the most lucrative method segment registering the fastest growth during the forecast period.


Sepsis diagnostics market data book summary

Market revenue in 2025USD 8.1 million
Market revenue in 2033USD 14.0 million
Growth rate7.1% (CAGR from 2026 to 2033)
Largest segmentConventional diagnostics
Fastest growing segmentAutomated Diagnostics
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAutomated Diagnostics, Conventional Diagnostics
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.7% of the global sepsis diagnostics market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2033.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 18.6 million by 2033.

The sepsis diagnostics market in South Africa is primarily driven by the high prevalence of infectious diseases, such as HIV/AIDS and tuberculosis, which elevate the risk of sepsis. Increasing awareness of sepsis and its critical health impact also fuels market growth.

The South African market is predominantly characterized by laboratory-based tests, including blood cultures, microbiology assays, and serological tests, which typically require several hours to days for results.

However, there is a growing demand for point-of-care diagnostic tests, such as Procalcitonin (PCT) & C-Reactive Protein (CRP) tests, which offer rapid results and facilitate swift treatment decisions. This shift toward more immediate diagnostic solutions is expected to influence the market in the near future significantly.

No credit card required*

Publish Date: Jun 10, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study
Turnaround
5–10 working days

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

NameProfile# EmployeesHQWebsite
Roche Holding AG ADRView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Koninklijke Philips NVView profile 73,712Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BCwww.philips.com
BioMerieux SAView profile 13,982Marcy l’Etoile, Lyon, France, 69280www.biomerieux.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Danaher CorpView profile 63,0002200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701www.danaher.com
Bruker CorpView profile 9,70740 Manning Road, Billerica, MA, United States, 01821www.bruker.com
BDView profile 10001+Franklin Lakes, New Jersey, United States, North Americawww.bd.com
LuminexView profile 501-1000Austin, Texas, United States, North Americawww.luminexcorp.com
CepheidView profile 1001-5000Sunnyvale, California, United States, North Americawww.cepheid.com
ImmunexpressView profile 11-50Seattle, Washington, United States, North Americawww.immunexpress.com

South Africa Sepsis Diagnostics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Sepsis Diagnostics Market Outlook will help companies and investors design strategic landscapes.


Conventional Diagnostics was the largest segment with a revenue share of 61.73% in 2025.

Horizon Databook has segmented the South Africa sepsis diagnostics market based on automated diagnostics, conventional diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.




The sepsis diagnostics market in South Africa is primarily driven by the high prevalence of infectious diseases, such as HIV/AIDS and tuberculosis, which elevate the risk of sepsis. Increasing awareness of sepsis and its critical health impact also fuels market growth.

The South African market is predominantly characterized by laboratory-based tests, including blood cultures, microbiology assays, and serological tests, which typically require several hours to days for results.

However, there is a growing demand for point-of-care diagnostic tests, such as Procalcitonin (PCT) & C-Reactive Protein (CRP) tests, which offer rapid results and facilitate swift treatment decisions. This shift toward more immediate diagnostic solutions is expected to influence the market in the near future significantly.

  • South Africa Sepsis Diagnostics Market Method Outlook (Revenue, USD Million , 2021-2033)
    • Automated Diagnostics
    • Conventional Diagnostics
  • South Africa Sepsis Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
    • Immunoassays
    • Others
    • Microbiology
    • Flow Cytometry
    • Molecular Diagnostics
  • South Africa Sepsis Diagnostics Market Pathogen Outlook (Revenue, USD Million , 2021-2033)
    • Bacterial Sepsis
    • Fungal Sepsis
    • Viral Sepsis and Others
  • South Africa Sepsis Diagnostics Market Testing Type Outlook (Revenue, USD Million , 2021-2033)
    • Laboratory Testing
    • Point-of-Care Testing
  • South Africa Sepsis Diagnostics Market End User Outlook (Revenue, USD Million , 2021-2033)
    • Hospitals & Clinics
    • Pathology & Reference Laboratories
    • Research Institutes and Others
  • South Africa Sepsis Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
    • Instruments
    • Blood Culture Media
    • Assay Kits & Reagents
    • Software

Reasons to subscribe to Sepsis Diagnostics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Sepsis Diagnostics Market Outlook databook

  • Our clientele includes a mix of Sepsis Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa Sepsis Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Africa Sepsis Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

South Africa Sepsis Diagnostics Market, 2021-2033 (US$M)

No Access Stack Chart

South Africa sepsis diagnostics market statistics, by method, 2021-2033 (US$M)

No Access Pie Chart

South Africa sepsis diagnostics market statistics, by method, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more